CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Open-market buy President bought 3,000 shares at $1.58 ($4,740)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.66 ($8,324)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise President acquired 94,564 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Exhibits
- 8-K Event Executive or director change
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
Page 15 of 33 · 659 filings